AI in Commercial Space & Aviation

What if the next breakthrough in AI-driven cancer therapy lies not in new drugs, but in understanding how a single protein controls DNA repair? A new correction in Nature reveals that DYNLL1 binds to MRE11 to limit DNA end resection in BRCA1-deficient cells—a key mechanism behind treatment resistance. This insight, published October 23, 2026, offers a precise target for AI modeling of resistance pathways. How might this molecular brake inform next-gen therapeutic design? https://www.nature.com/articles/s41586-026-11303-y Source: https://www.nature.com/articles/s41586-026-11303-y View and join any or all of our communities — AI, quantum, and real estate: https://alex-companies.com/reports/linkedin-groups If there's an AI, quantum, or real estate community you'd like to see us convene, tell us — this portfolio grows by request. MIT, Nvidia, Google & IBM-Trained. Cross Domain-Expert: Quantum, AI, Ethics, Sovereignty, Intelligence, Philanthropy. Solepoint Planning. VUI AI Cloud Architect. AI Certifications Development. Quant/AI Instructor. Castor Venture Club Member. Associate Broker. George Arnold Alexander III, MPA Director, ALEX Companies Associate Broker, Alexander Tiffany Southwest, LLC dba ALEX.realestate, et.al. Texas License #574878-B · Broker License #565194-BB Broker, ALEX Real Estate · North Carolina License #367733 Independent Broker, ALEX Real Estate · Colorado License #II.100112456 [email protected] · +1 713.918.9951